| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient
|
Pitini, V.
|
|
|
15 |
9 |
p. 1446
|
artikel
|
| 2 |
Adjuvant therapy for stage II colon cancer: an elephant in the living room?
|
Zaniboni, A.
|
|
|
15 |
9 |
p. 1310-1318
|
artikel
|
| 3 |
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
|
Tabernero, J.
|
|
|
15 |
9 |
p. 1358-1365
|
artikel
|
| 4 |
A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
|
Hong, Y.S.
|
|
|
15 |
9 |
p. 1344-1347
|
artikel
|
| 5 |
A word in your ear: the 2004 Annals of Oncology prizes
|
Kerr, David J.
|
|
|
15 |
9 |
p. 1303-1304
|
artikel
|
| 6 |
BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients
|
Rogozińska-Szczepka, J.
|
|
|
15 |
9 |
p. 1373-1376
|
artikel
|
| 7 |
Complete disappearance of multiple periorbital xanthelasmata after chemotherapy for primary extragonadal germ-cell mediastinal tumor
|
Eleftheriades, D.
|
|
|
15 |
9 |
p. 1445-1446
|
artikel
|
| 8 |
Cyclooxygenase-2 inhibitor and cisplatin combination as a radiosensitizer in the treatment of head and neck cancer patients
|
Altundag, O.
|
|
|
15 |
9 |
p. 1444-1445
|
artikel
|
| 9 |
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy
|
Cavaletti, G.
|
|
|
15 |
9 |
p. 1439-1442
|
artikel
|
| 10 |
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials
|
Folprecht, G.
|
|
|
15 |
9 |
p. 1330-1338
|
artikel
|
| 11 |
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
|
Schmoll, H.J.
|
|
|
15 |
9 |
p. 1377-1399
|
artikel
|
| 12 |
Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma
|
Yamamoto, S.
|
|
|
15 |
9 |
p. 1432-1438
|
artikel
|
| 13 |
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study
|
André, T.
|
|
|
15 |
9 |
p. 1339-1343
|
artikel
|
| 14 |
Identifying subgroups among poor prognosis patients with nonseminomatous germ cell cancer by tree modelling: a validation study
|
van Dijk, M.R.
|
|
|
15 |
9 |
p. 1400-1405
|
artikel
|
| 15 |
Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index
|
Bertz, H.
|
|
|
15 |
9 |
p. 1419-1424
|
artikel
|
| 16 |
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma
|
Rao, S.
|
|
|
15 |
9 |
p. 1413-1418
|
artikel
|
| 17 |
Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy
|
Kim, S.-J.
|
|
|
15 |
9 |
p. 1352-1357
|
artikel
|
| 18 |
Prognostic relevance of cell proliferation in head and neck tumors
|
Pich, A.
|
|
|
15 |
9 |
p. 1319-1329
|
artikel
|
| 19 |
Reply to the Letter to the Editor on “Topotecan versus paclitaxel in second-line therapy: a lost opportunity for quality-of-life evaluation?”, by G. Apolone & A. Buda (Ann Oncol 2004; 15: 1443–1444)
|
Ross, G.A.
|
|
|
15 |
9 |
p. 1444
|
artikel
|
| 20 |
Safety of sentinel node biopsy in pregnant patients with breast cancer
|
Gentilini, O.
|
|
|
15 |
9 |
p. 1348-1351
|
artikel
|
| 21 |
Table of Contents
|
|
|
|
15 |
9 |
p. i-ii
|
artikel
|
| 22 |
The international quality requirements for the conduct of clinical studies and the challenges for study centers to implement them
|
Gajic, A.
|
|
|
15 |
9 |
p. 1305-1309
|
artikel
|
| 23 |
The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma
|
Andreopoulou, E.
|
|
|
15 |
9 |
p. 1406-1412
|
artikel
|
| 24 |
Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancer
|
Saif, M.W.
|
|
|
15 |
9 |
p. 1366-1372
|
artikel
|
| 25 |
Topotecan versus paclitaxel in second-line therapy: a lost opportunity for quality-of-life evaluation?
|
Apolone, G.
|
|
|
15 |
9 |
p. 1443-1444
|
artikel
|
| 26 |
Trends in cancer mortality in the European Union and accession countries, 1980–2000
|
Levi, F.
|
|
|
15 |
9 |
p. 1425-1431
|
artikel
|
Tijdschrift beschrijving